Prevention and management of glucocorticoid-induced side effects: A comprehensive review
- 1 January 2017
- journal article
- review article
- Published by Elsevier BV in Journal of the American Academy of Dermatology
- Vol. 76 (1), 1-9
- https://doi.org/10.1016/j.jaad.2016.01.062
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Bisphosphonate Therapy for Osteoporosis: Benefits, Risks, and Drug HolidayAmerican Journal Of Medicine, 2013
- The effect of 3 versus 6 years of Zoledronic acid treatment of osteoporosis: A randomized extension to the HORIZON-Pivotal Fracture Trial (PFT)Journal of Bone and Mineral Research, 2011
- Uncertainties in the prevention and treatment of glucocorticoid-induced osteoporosisJournal of Bone and Mineral Research, 2011
- Preventing vitamin D toxicity in patients with sarcoidosisJournal of the American Academy of Dermatology, 2011
- Long-term exposure to medium-dose glucocorticoid therapy associates with hypertension in patients with rheumatoid arthritisRheumatology, 2008
- Bisphosphonate-Associated Osteonecrosis of the Jaw: Report of a Task Force of the American Society for Bone and Mineral ResearchJournal of Bone and Mineral Research, 2007
- High prevalence of asymptomatic vertebral fractures in post-menopausal women receiving chronic glucocorticoid therapy: A cross-sectional outpatient studyBone, 2006
- Pharmacokinetics and Pharmacodynamics of Systemically Administered GlucocorticoidsClinical Pharmacokinetics, 2005
- Transplacental effects of bisphosphonates on fetal skeletal ossification and mineralization in ratsTeratology, 1999
- Clinical Pharmacokinetics of Prednisone and PrednisoloneClinical Pharmacokinetics, 1990